Literature DB >> 23556869

Point/Counterpoint. IGRT has limited clinical value due to lack of accurate tumor delineation.

Christopher F Njeh1, Lei Dong, Colin G Orton.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23556869     DOI： 10.1118/1.4789492

Source DB:  PubMed          Journal:  Med Phys        ISSN： 0094-2405            Impact factor:   4.071


× No keyword cloud information.
  6 in total

Review 1.  The future of image-guided radiotherapy will be MR guided.

Authors:  Julianne M Pollard; Zhifei Wen; Ramaswamy Sadagopan; Jihong Wang; Geoffrey S Ibbott
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

2.  A multimodality segmentation framework for automatic target delineation in head and neck radiotherapy.

Authors:  Jinzhong Yang; Beth M Beadle; Adam S Garden; David L Schwartz; Michalis Aristophanous
Journal:  Med Phys       Date:  2015-09       Impact factor: 4.071

3.  Coverage-based treatment planning to accommodate delineation uncertainties in prostate cancer treatment.

Authors:  Huijun Xu; J James Gordon; Jeffrey V Siebers
Journal:  Med Phys       Date:  2015-09       Impact factor: 4.071

4.  Intensity-Modulated Proton Therapy Adaptive Planning for Patients with Oropharyngeal Cancer.

Authors:  Richard Y Wu; Amy Y Liu; Terence T Sio; Pierre Blanchard; Cody Wages; Mayankkumar V Amin; Gary B Gunn; Uwe Titt; Rong Ye; Kazumichi Suzuki; Michael T Gillin; Xiaorong R Zhu; Radhe Mohan; Steven J Frank
Journal:  Int J Part Ther       Date:  2017-12-28

5.  Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry.

Authors:  Kareem A Wahid; Sara Ahmed; Renjie He; Lisanne V van Dijk; Jonas Teuwen; Brigid A McDonald; Vivian Salama; Abdallah S R Mohamed; Travis Salzillo; Cem Dede; Nicolette Taku; Stephen Y Lai; Clifton D Fuller; Mohamed A Naser
Journal:  Clin Transl Radiat Oncol       Date:  2021-10-16

6.  Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?

Authors:  Barbara Segedin; Primoz Petric
Journal:  Radiol Oncol       Date:  2016-05-09       Impact factor: 2.991
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.